Journal: Oncology Research and Treatment
Extended Submission Deadline: October 31, 2024
The emergence of liquid biopsy as a promising tool in the diagnosis and monitoring of solid tumors has revolutionized the landscape of oncology. Current research in the field of liquid biopsy in solid tumors includes:
- Exploration of the technical challenges and advancements in the detection of circulating tumor biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs); from sample collection to data interpretation.
- Investigations into sensitivity, specificity, and reliability of various liquid biopsy techniques and comparative studies evaluating the efficacy of liquid biopsy as a standalone diagnostic tool or its complementarity to traditional tissue biopsies.
- Discussions on the clinical implications, advantages, and limitations of integrating liquid biopsy into routine diagnostic protocols.
- Exploration of quantitative approaches to assess minimal residual disease (MRD) using liquid biopsy and its implications for treatment decision-making.
- The potential of liquid biopsy in early cancer detection and screening, with a focus on methylation panels.
- The use of liquid biopsy in various solid tumors, including, but not limited to, early and metastatic breast cancer, colorectal cancer, and bladder cancer.
We are calling for contributions to an article collection dedicated to emerging insights on clinical and research questions that address the critical impact of liquid biopsy in diagnosis and treatment of solid tumors. We will consider original research articles, brief reports, and review articles.
Accepted articles will be published in an article collection in Oncology Research and Treatment entitled “Liquid Biopsy in Diagnosis and Treatment Monitoring of Solid Tumors”.
Please select the option “Call for Papers: Liquid Biopsy in Diagnosis and Treatment Monitoring of Solid Tumors” when submitting your manuscript and mention this Call for Papers in your cover letter.
Oncology Research and Treatment supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.
Check out the Author Guidelines.